Letter to the editor: Triclosan in patients with inflammatory bowel disease | Med. oral patol. oral cir. bucal (Internet);27(5): e442-e443, September 01, 2022. | IBECS

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Letter to the editor: Triclosan in patients with inflammatory bowel disease

Peña-Cardelles, Juan Francisco.

Affiliation

Peña-Cardelles, Juan Francisco; Spanish Association of Crohn Disease and Ulcerative Colitis (ACCU). Spain

Med. oral patol. oral cir. bucal (Internet) ; 27(5): e442-e443, September 01, 2022.

Article in En | IBECS | ID: ibc-209810

Responsible library: ES1.1

Localization: ES15.1 - BNCS

Subject(s)

Humans; Chronic Disease; Inflammatory Bowel Diseases/drug therapy; Triclosan/therapeutic use

Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Triclosan / Inflammatory Bowel Diseases / Chronic Disease Limits: Humans Language: En Journal: Med. oral patol. oral cir. bucal (Internet) Year: 2022 Document type: Article

Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Triclosan / Inflammatory Bowel Diseases / Chronic Disease Limits: Humans Language: En Journal: Med. oral patol. oral cir. bucal (Internet) Year: 2022 Document type: Article